201 related articles for article (PubMed ID: 28661438)
1. Macular Carotenoid Supplementation Improves Visual Performance, Sleep Quality, and Adverse Physical Symptoms in Those with High Screen Time Exposure.
Stringham JM; Stringham NT; O'Brien KJ
Foods; 2017 Jun; 6(7):. PubMed ID: 28661438
[TBL] [Abstract][Full Text] [Related]
2. Macular carotenoid supplementation improves disability glare performance and dynamics of photostress recovery.
Stringham JM; O'Brien KJ; Stringham NT
Eye Vis (Lond); 2016; 3():30. PubMed ID: 27857944
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.
Hammond BR; Fletcher LM; Roos F; Wittwer J; Schalch W
Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8583-9. PubMed ID: 25468896
[TBL] [Abstract][Full Text] [Related]
4. Macular Pigment Response to Lutein, Zeaxanthin, and Meso-zeaxanthin Supplementation in Open-Angle Glaucoma: A Randomized Controlled Trial.
Loughman J; Loskutova E; Butler JS; Siah WF; O'Brien C
Ophthalmol Sci; 2021 Sep; 1(3):100039. PubMed ID: 36247822
[TBL] [Abstract][Full Text] [Related]
5. Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation.
Stringham JM; Stringham NT
Exp Eye Res; 2016 Oct; 151():1-8. PubMed ID: 27426932
[TBL] [Abstract][Full Text] [Related]
6. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
Stringham NT; Holmes PV; Stringham JM
Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
[TBL] [Abstract][Full Text] [Related]
7. Macular pigment and visual performance under glare conditions.
Stringham JM; Hammond BR
Optom Vis Sci; 2008 Feb; 85(2):82-8. PubMed ID: 18296924
[TBL] [Abstract][Full Text] [Related]
8. Contrast Sensitivity and Lateral Inhibition Are Enhanced With Macular Carotenoid Supplementation.
Stringham JM; O'Brien KJ; Stringham NT
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2291-2295. PubMed ID: 28431432
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
[TBL] [Abstract][Full Text] [Related]
10. Supplementation with macular carotenoids reduces psychological stress, serum cortisol, and sub-optimal symptoms of physical and emotional health in young adults.
Stringham NT; Holmes PV; Stringham JM
Nutr Neurosci; 2018 May; 21(4):286-296. PubMed ID: 28198205
[TBL] [Abstract][Full Text] [Related]
11. Lutein and Zeaxanthin Supplementation Improves Dynamic Visual and Cognitive Performance in Children: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study.
Parekh R; Hammond BR; Chandradhara D
Adv Ther; 2024 Apr; 41(4):1496-1511. PubMed ID: 38363462
[TBL] [Abstract][Full Text] [Related]
12. Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance.
Kvansakul J; Rodriguez-Carmona M; Edgar DF; Barker FM; Köpcke W; Schalch W; Barbur JL
Ophthalmic Physiol Opt; 2006 Jul; 26(4):362-71. PubMed ID: 16792735
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.
Connolly EE; Beatty S; Thurnham DI; Loughman J; Howard AN; Stack J; Nolan JM
Curr Eye Res; 2010 Apr; 35(4):335-51. PubMed ID: 20373901
[TBL] [Abstract][Full Text] [Related]
14. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery.
Nolan JM; O'Reilly P; Loughman J; Stack J; Loane E; Connolly E; Beatty S
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4777-85. PubMed ID: 19628740
[TBL] [Abstract][Full Text] [Related]
16. Correlations between internal and external ocular factors and macular pigment optical density.
Tudosescu R; Alexandrescu CM; Istrate SL; Vrapciu AD; Ciuluvică RC; Voinea L
Rom J Ophthalmol; 2018; 62(1):42-47. PubMed ID: 29796433
[TBL] [Abstract][Full Text] [Related]
17. Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations.
Aleman TS; Cideciyan AV; Windsor EA; Schwartz SB; Swider M; Chico JD; Sumaroka A; Pantelyat AY; Duncan KG; Gardner LM; Emmons JM; Steinberg JD; Stone EM; Jacobson SG
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1319-29. PubMed ID: 17325179
[TBL] [Abstract][Full Text] [Related]
18. Macular pigment optical density at four retinal loci during 120 days of lutein supplementation.
Wenzel AJ; Sheehan JP; Gerweck C; Stringham JM; Fuld K; Curran-Celentano J
Ophthalmic Physiol Opt; 2007 Jul; 27(4):329-35. PubMed ID: 17584283
[TBL] [Abstract][Full Text] [Related]
19. Macular pigment is associated with glare-affected visual function and central visual field loss in glaucoma.
Siah WF; O'Brien C; Loughman JJ
Br J Ophthalmol; 2018 Jul; 102(7):929-935. PubMed ID: 28982957
[TBL] [Abstract][Full Text] [Related]
20. The impact of macular pigment augmentation on visual performance using different carotenoid formulations.
Loughman J; Nolan JM; Howard AN; Connolly E; Meagher K; Beatty S
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7871-80. PubMed ID: 23132800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
